Literature DB >> 21616038

Roles of autoantibodies in central nervous system injury.

Yi Zhang1, Phillip Popovich.   

Abstract

Stroke, traumatic brain injury (TBI), and spinal cord injury (SCI) cause irreversible damage to the nervous system. Although these are neurological disorders, pathology and loss of function also occur outside the nervous system and are often not easily explained by paralysis or impaired neural function. Emerging data indicate that much of the pathological sequelae that accompanies CNS trauma has characteristics of a self-directed immunological disease. Here, we outline those data, describing basic mechanisms of B cell activation and autoantibody synthesis after CNS injury. A summary of the anti-CNS autoantibodies that have been identified in humans and animals is provided along with a discussion of how autoantibodies may affect survival of neuronal and non-neuronal tissues and whether autoimmune reactions are feasible therapeutic targets after CNS trauma.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21616038

Source DB:  PubMed          Journal:  Discov Med        ISSN: 1539-6509            Impact factor:   2.970


  7 in total

1.  Nervous system autoantibodies and vitamin D receptor gene polymorphisms in hemodialysis patients.

Authors:  Darius L Mason; Magdalene M Assimon; Jeffrey R Bishop; Hassan A N El-Fawal
Journal:  Hemodial Int       Date:  2012-08-15       Impact factor: 1.812

Review 2.  The Next Generation of Biomarker Research in Spinal Cord Injury.

Authors:  Elke Ydens; Ilse Palmers; Sven Hendrix; Veerle Somers
Journal:  Mol Neurobiol       Date:  2016-02-05       Impact factor: 5.590

3.  Fenbendazole improves pathological and functional recovery following traumatic spinal cord injury.

Authors:  C G Yu; R Singh; C Crowdus; K Raza; J Kincer; J W Geddes
Journal:  Neuroscience       Date:  2013-10-30       Impact factor: 3.590

4.  The prevalence of autoantibodies in complex regional pain syndrome type I.

Authors:  Maaike Dirckx; Marco W J Schreurs; Marissa de Mos; Dirk L Stronks; Frank J P M Huygen
Journal:  Mediators Inflamm       Date:  2015-02-08       Impact factor: 4.711

5.  Natural IgM antibodies that bind neoepitopes exposed as a result of spinal cord injury , drive secondary injury by activating complement.

Authors:  Aarti Narang; Fei Qiao; Carl Atkinson; Hong Zhu; Xiaofeng Yang; Liudmila Kulik; V Michael Holers; Stephen Tomlinson
Journal:  J Neuroinflammation       Date:  2017-06-19       Impact factor: 8.322

Review 6.  Blood Biomarkers for Traumatic Brain Injury: A Quantitative Assessment of Diagnostic and Prognostic Accuracy.

Authors:  Zoe S Gan; Sherman C Stein; Randel Swanson; Shaobo Guan; Lizette Garcia; Devanshi Mehta; Douglas H Smith
Journal:  Front Neurol       Date:  2019-04-26       Impact factor: 4.003

7.  Fcγ receptor-mediated inflammation inhibits axon regeneration.

Authors:  Gang Zhang; Nataliia Bogdanova; Tong Gao; Julia J Song; Mark S Cragg; Martin J Glennie; Kazim A Sheikh
Journal:  PLoS One       Date:  2014-02-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.